Termination Reimbursement scheme Forxiga®/Xigduo® - Diabetes
As from the 1st of August 2025 the “bijlage 2 voorwaarden” for Forxiga® and Xigduo® have been withdrawn. This means that per 1st...
Termination Reimbursement scheme Cresemba® 40 mg en 100mg
From August 1st 2025 onwards, Cresemba® 40 mg en 100mg is fully reimbursed by the health insurer. Therefore the...
Update Reimbursement Scheme Cresemba®
The health insurer does not fully reimburse Cresemba® 40 mg and 100 mg. The producer of this medicine has therefore asked TBR...
Update Reimbursement Scheme Metoject®
From January 1, 2025 the use of Metoject Pen® 7.5mg will be fully reimbursed by the Health Insurer. For this reason the...
Reimbursement Scheme Veoza®
Reimbursement Scheme for VEOZA® (fezolinetant) 45 mg for the treatment of moderate to severe vasomotor symptoms (VMS) associated...
Select your medicine
Check your medicine expenses
Quickly check the maximum contribution you have to pay for your medicine